Article
NCOA4 is a Prognostic Biomarker Associated with Immune Infiltrates in Glioblastoma
2022-03-02
Abstract excerpt
<h4>Background: </h4> Glioblastoma (GBM) is a malignant primary craniocerebral tumor with median survival of less than 15 months. Nuclear receptor coactivator 4 (NCOA4) can regulate the growth of various malignant tumors by participating in various biological processes. However, in glioblastoma, the specific regulatory role and mechanism of NCOA4 have not been clearly explained. <h4>Methods: </h4> We collected GBM...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ab2ff7f6-8ce1-5b94-be1d-bed0109bc4bb
- DOI
- 10.21203/rs.3.rs-1326253/v2
